← Open Payments lookup

KATHLEEN KILCOYNE: Open Payments

NPI 1639335862 · DENVILLE, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,867 in 72 payments from 11 companies in 2025. Trend: 2023 $1,604 · 2024 $2,060 · 2025 $1,867

Food & beverage: $1,867
CompanyPaymentsAmount
Teva Pharmaceuticals USA, Inc.8$330
Axsome Therapeutics, Inc.12$271
E.R. Squibb & Sons, L.L.C.3$254
Otsuka America Pharmaceutical, Inc.5$226
ABBVIE INC.20$203
Alkermes, Inc.6$165
Supernus Pharmaceuticals, Inc.1$125
Neurocrine BioSciences, Inc.6$111
Lundbeck LLC5$92
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)5$73

Products named: COBENFY, REXULTI, Auvelity, VRAYLAR, AUSTEDO XR, UZEDY, Qelbree, INGREZZA.

Industry payments across NJ — which companies pay providers there.